Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Prefer Tech Mahindra, says Vishal Jajoo

      Vishal Jajoo, Senior Equity Research Analyst at Nirmal Bang Securities prefers Tech Mahindra.

    • Is the risk reward in Cipla still favourable?

      Cipla is poised for good growth going forward but valuations is the only weak link possibly the weak link in Cipla's performance going forward. At around 22-23 times our take is that fresh investments can possibly wait for declines or discount, says Mayuresh Joshi of Angel Broking.

    • Cipla may rise by 15-20%, says Phani Sekhar

      Phani Sekhar, Fund Manager-PMS at Angel Broking feels that 15-20 percent upside is possible in Cipla in one year.

    • Buy Dolphin Offshore, Pennar Industries, Cipla: Pankaj Jain

      Pankaj Jain, Director at Sunteck Wealthmax Capital is of the view that one can buy Dolphin Offshore, Pennar Industries, Cipla and Motherson Sumi Systems.

    • Buy Cipla, says Kunj Bansal

      Kunj Bansal of Centrum Wealth Management recommends buying Cipla.

    • Buy Bharat Forge, Cipla, IDBI Bank: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Bharat Forge, IDBI Bank and Cipla.

    • Satish Ramanathan positive on pharma sector

      Satish Ramanathan, Market Analyst has a positive view on the pharma sector.

    • Buy Cipla on declines; may test Rs 750: Nooresh Merani

      Nooresh Merani, CEO at Analyse India is of the view that one may buy Cipla on declines.

    • Buy Cipla on dips, says Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com advises buying Cipla on dips.

    • Stay invested in Cipla, says Mayuresh Joshi

      Mayuresh Joshi, VP- Institution at Angel Broking is of the view that one may stay invested in Cipla.

    • Hold or Sell: How to play your favourite stocks

      Watch the interview of Mayuresh Joshi, VP- Institution of Angel Broking Ltd and Kunal Saraogi, CEO of Equityrush with Sumaira Abidi & Nigel D'Souza on CNBC-TV18, in which they shared their reading and outlook on market and specific stocks.

    • Dipan Mehta overweight on Cipla

      Dipan Mehta, Member at BSE & NSE is overweight on Cipla.

    • Hold Cipla, says Kunal Saraogi

      Kunal Saraogi, CEO of Equityrush recommends holding Cipla with a long term view.

    • CIMB sees earnings upgrade for Cipla in FY16

      CIMB has a target price of Rs 600 on Cipla valued at 21 times one-year forward.

    • Nilesh Shah cautious on pharma sector

      Nilesh Shah, MD & CEO of Envision Capital is cautious on the pharmaceutical sector.

    • See upside in Cipla, says Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may see more upside in Cipla.

    • Prefer Infosys, Tech Mahindra, Hexaware: CK Narayan

      According to CK Narayan, MD of Growth Avenues, one may prefer Infosys, Tech Mahindra and Hexaware Technologies from IT space.

    • Cipla may touch Rs 545-550: Pritesh Mehta

      Pritesh Mehta, senior technical analyst at IIFL is of the view that Cipla may touch Rs 545-550.

    • Buy Cipla on dips, says Deven Choksey

      Deven Choksey of KR Choksey Shares & Securities is of the view that one may buy Cipla on dips.

    • Prefer Cipla, Sun Pharma, Dr Reddys: Phani Sekhar

      According to Phani Sekhar of Angel Broking, one may prefer Cipla, Sun Pharmaceuticals and Dr Reddy‘s Laboratories in pharma space.

    • Avoid Ranbaxy; prefer Cipla, Biocon: Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may avoid Ranbaxy Laboratories and prefer Biocon, Ipca Laboratories and Cipla from the pharmaceutical space.

    • Buy Cipla, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Cipla on dips as the stock may go back to its earlier highs.

    • Buy Cipla, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may buy Cipla as the stock may rally.

    • Sell Aurobindo Pharma, NTPC; buy Cipla: SP Tulsian

      According to SP Tulsian of sptulsian.com, one may sell NTPC with a target of Rs 111.50.

    • Super Six stocks you can bet on February 26

      Hemen Kapadia of KR Choksey Securities advises buying Cipla with a target of Rs 380 and Havells India with a target of Rs 787.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347